Disseminated systemic Nocardia farcinica infection complicating alefacept and infliximab therapy in a patient with severe psoriasis

International Journal of Infectious Diseases

Volumn 14, Issue 2, 2010, Pages

  Al Tawfiq, Jaffar A ^a   Al Khatti, Adil A ^a  

^a DHAHRAN HEALTH CENTER   (Saudi Arabia)

Author keywords

Alefacept; Anti TNF; Brain abscess; Infliximab; Nocardia farcinica; Psoriasis

Indexed keywords

ALEFACEPT; AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFTRIAXONE; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; GATIFLOXACIN; IMIPENEM; INFLIXIMAB; LINEZOLID; MEROPENEM; MOXIFLOXACIN; SULFAMETHOXAZOLE; TOBRAMYCIN; VANCOMYCIN; VORICONAZOLE;

ADRENAL GLAND; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ASPIRATION BIOPSY; BACTERIAL GROWTH; BLOOD CULTURE; BRAIN; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DISSEMINATED SYSTEMIC NOCARDIA FARCINICA INFECTION; DNA SEQUENCE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCOMPROMISED PATIENT; LABORATORY TEST; LYMPH NODE; NOCARDIA FARCINICA; NOCARDIOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PSORIASIS;

AGED; ANTIBODIES, MONOCLONAL; DERMATOLOGIC AGENTS; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; NOCARDIA; NOCARDIA INFECTIONS; PSORIASIS; RECOMBINANT FUSION PROTEINS; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 76649132010     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2009.03.017     Document Type: Article

References (23)

1. McNeil M.M., and Brown J.M. The medically important actinomycetes: epidemiology and microbiology. Clin Microbiol Rev 7 (1994) 357-417
2. Burgert S.J. Nocardiosis: a clinical review. Infect Dis Clin Pract 8 (1999) 27-32
3. Sabuncuoǧlu H., Cibali Açikgo Z.Z., Caydere M., Ustün H., and Semih Keskil I. Nocardia farcinica brain abscess: a case report and review of the literature. Neurocirugia (Astur) 15 (2004) 600-603
4. Wallis R.S., Broder M., Wong J., and Beenhouwer D. Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis 38 (2004) 1261-1265
5. Wallis R.S., Broder M., Wong J., and Beenhouwer D. Granulomatous infections due to tumor necrosis factor blockade: correction. Clin Infect Dis 39 (2004) 1254-1255
6. Fabre S., Gibert C., Lechiche C., Jorgensen C., and Sany J. Primary cutaneous Nocardia otitidiscaviarum infection in a patient with rheumatoid arthritis treated with infliximab. J Rheumatol 32 (2005) 2432-2433
7. Singh S.M., Rau N.V., Cohen L.B., and Harris H. Cutaneous nocardiosis complicating management of Crohn's disease with infliximab and prednisone. CMAJ 171 (2004) 1063-1064
8. Menon K.V., Stadheim L., Kamath P.S., Wiesner R.H., Gores G.J., Peine C.J., et al. A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitis. Am J Gastroenterol 99 (2004) 255-260
9. Scheinfeld N.J. Alefacept: its safety profile, off-label uses, and potential as part of combination therapies for psoriasis. J Dermatolog Treat 18 (2007) 197-208
10. Prasertsuntarasai T., and Bello E.F. Mycobacterium avium complex olecranon bursitis in a patient treated with alefacept. Mayo Clin Proc 80 (2005) 1532-1533
11. Vamvouris T., and Hadi S. A review of the treatment of psoriasis with infliximab. Rev Recent Clin Trials 1 (2006) 201-205
12. Toruner M., Loftus Jr. E.V., Harmsen W.S., Zinsmeister A.R., Orenstein R., Sandborn W.J., et al. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology 134 (2008) 929-936
13. Wendling D., Murad M., Mathieu S., Berger E., and Rumbach L. Systemic nocardiosis in a case of rheumatoid arthritis treated with tumor necrosis factor blockers. J Rheumatol 35 (2008) 539-542
14. Doraiswamy V.A. Nocardia infection with adalimumab in rheumatoid arthritis. J Rheumatol 35 (2008) 542-543
15. Torres O.H., Domingo P., Pericas R., Boiron P., Montiel J.A., and Vázquez G. Infection caused by Nocardia farcinica: case report and review. Eur J Clin Microbiol Infect Dis 19 (2000) 205-212
16. Wauters G., Avesani V., Charlier J., Janssens M., Vaneechoutte M., and Delmee M. Distribution of Nocardia species in clinical samples and their routine rapid identification in the laboratory. J Clin Microbiol 43 (2005) 2624-2628
17. Cercenado E., Marin M., Sanchez-Martinez M., Cuevas O., Martinez-Alarcon J., and Bouza E. In vitro activities of tigecycline and eight other antimicrobials against different Nocardia species identified by molecular methods. Antimicrob Agents Chemother 51 (2007) 1102-1104
18. Wallace Jr. R.J., Steele L.C., Sumter G., and Smith J.M. Antimicrobial susceptibility patterns of Nocardia asteroides. Antimicrob Agents Chemother 32 (1988) 1776-1779
19. Aydoslu B., and Tuǧrul H.M. Nocardia spp isolated from immunocompromised patients in Trakya University Medical Faculty Hospital and their antibiotic susceptibilities. Mikrobiyol Bul 41 (2007) 529-535
20. Dodds E.M., Echandi L.V., Puente S.I., and Kaufman S. Subretinal abscess due to Nocardia farcinica resistant to trimethoprim-sulfamethoxazole in a patient with systemic lupus erythematosus. Ocul Immunol Inflamm 14 (2006) 249-251
21. Mamelak A.N., Obana W.G., Flaherty J.F., and Rosenblum M.L. Nocardia brain abscess: treatment strategies and factors influencing outcome. Neurosurgery 35 (1994) 622-631
22. Steingrube V.A., Brown B.A., Gibson J.L., Wilson R.W., Brown J., Blacklock Z., et al. DNA amplification and restriction endonuclease analysis for differentiation of 12 different species and taxa of Nocardia, including recognition of four new taxa within the Nocardia asteroides complex. J Clin Microbiol 33 (1995) 3096-3101
23. Iannotti C.A., Hall G.S., Procop G.W., Tuohy M.J., Staugaitis S.M., and Weil R.J. Solitary Nocardia farcinica brain abscess in an immunocompetent adult mimicking metastatic brain tumor: rapid diagnosis by pyrosequencing and successful treatment. Surg Neurol (2008) [Epub ahead of print]